INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
18
DD
Duffy Kristine DDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$7,506
195 sh
Jun 17, 2026Jun 22, 2026
Page 658 of 1737
← PrevNext →
traded Jun 17, 2026
+5d
SEC Form 4

Evidence

18
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$281K
4,582 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DO
Donnally James ODirector
INVInnventure, Inc.
Gift
G—
22.3K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
3,401 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DM
Dawsey James MDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$14K
373 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
MC
Morris Philip CDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$7,506
195 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$335K
5,418 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DO
Donnally James ODirector
INVInnventure, Inc.
Gift
G—
22.3K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

17
NH
Neubauer Caroll HDirector
BFLYButterfly Network, Inc.
Grant or award
A—
25.4K sh
Jun 22, 2026Jun 22, 2026
traded Jun 22, 2026
+0dSEC Form 4

Evidence

17
EH
Evans Jeffrey HerbertDirector
LCUTLIFETIME BRANDS, INC
Grant or award
A—
12.4K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

17
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A$13K
7,907 sh
Jun 19, 2026Jun 22, 2026
traded Jun 19, 2026
+3dSEC Form 4

Evidence

16
CT
Cox TroyDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$108K
19.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
HL
Hibbs Kathy LDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
CM
Cossery Jean-MichelDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$108K
19.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
HD
Hirsch DidierDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
CT
Cox TroyDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
43.1K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
HD
Hirsch DidierDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$108K
19.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

15
TP
Thiara ParvinderDirector
ZURAZura Bio Ltd
Grant or award
A—
51.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
FR
Frieson RonDirector
AKBAAkebia Therapeutics, Inc.
Grant or award
A—
53.6K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
MS
Mclaughlin Sean SamuelDirector
CIACITIZENS, INC.
Grant or award
A—
7,042 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
MV
Malyala VikranthSVP, Chief Business Officer
SMCISuper Micro Computer, Inc.
Grant or award
A—
15.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
KH
Kuhl HenrikDirector
EVLVEvolv Technologies Holdings, Inc.
Option exercise
M—
9,291 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
ES
Escovar Gomez SylviaDirector
CIBGrupo Cibest S.A.
Grant or award
A$3,673
465 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
WH
Woersching Eric H.Director
BLNDBlend Labs, Inc.
Grant or award
A—
50.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
FM
Fallon Catriona MDirector
INVInnventure, Inc.
Grant or award
A—
18.2K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
CC
Carriedo CarlosCOO, Amer. Payments & Mobility
WEXWEX Inc.
Tax withholding
F$23K
174 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
CE
Choi EmilieDirector
OKTAOkta, Inc.
Option exercise
M—
2,487 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
SD
Sirkel Jason D.Chief Banking Officer
STELStellar Bancorp, Inc.
Option exercise
M—
30.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
MG
Meltzer GaryDirector
SOFISoFi Technologies, Inc.
Option exercise
M—
2,823 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
KH
Kuhl HenrikDirector
EVLVEvolv Technologies Holdings, Inc.
Option exercise
M—
9,291 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
EM
Eisner MarkDirector
ZURAZura Bio Ltd
Grant or award
A—
51.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
VS
Vatnick SilvinaDirector
CIBGrupo Cibest S.A.
Grant or award
A$3,937
498 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
NA
Nirula AjayDirector
ZURAZura Bio Ltd
Grant or award
A—
51.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
MD
Mounts Gonzales DavidDirector
EVLVEvolv Technologies Holdings, Inc.
Option exercise
M—
27.1K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
MV
Malyala VikranthSVP, Chief Business Officer
SMCISuper Micro Computer, Inc.
Option exercise
M—
7,500 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
CC
Carriedo CarlosCOO, Amer. Payments & Mobility
WEXWEX Inc.
Option exercise
M—
391 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
CC
Carriedo CarlosCOO, Amer. Payments & Mobility
WEXWEX Inc.
Option exercise
M—
391 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$119K
3,316 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

15
JR
Jaramillo Mejia RicardoDirector
CIBGrupo Cibest S.A.
Grant or award
A$2,237
283 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence